Author:
Mohr Erich,Feldman Howard,Gauthier Serge
Abstract
ABSTRACT:The magnitude of the problems faced by Canadian society as a result of an aging population has been identified. Perhaps the most important concern related to this greying of Canada is the increasing incidence of dementia and Alzheimer’s disease. Therapeutic options for these disorders have been limited to date. Advances in biotechnology and molecular biology will offer novel approaches to treatment. These and the expansion of more traditional therapeutic avenues require guidelines with the aim of optimizing their development.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Neurology,Neurology,General Medicine
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dementia services in Canada;International Journal of Geriatric Psychiatry;2010-08-23
2. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort;International Psychogeriatrics;2008-07-08
3. Issues in Design and Conduct of Clinical Trials for Cognitive-Enhancing Drugs;Animal and Translational Models for CNS Drug Discovery;2008
4. Improving Drug Trials for Mild to Moderate Alzheimer's Disease;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2007-03
5. Disease Staging and Milestones;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2007-03